What Mounjaro Is
Mounjaro is the brand name for tirzepatide, a once-weekly injection first approved for type 2 diabetes and since studied extensively for weight. It acts on two hormone receptors at once, known as GLP-1 and GIP. These are the receptors for incretins, hormones your gut releases after a meal to tell your body that it has eaten.
That dual action is what separates it from the earlier generation of weight medicines, which acted on GLP-1 alone.
How It Works
In plain terms, it does three things. It slows how quickly your stomach empties, so a meal keeps you full for longer. It acts on the appetite centres in the brain, so hunger quietens, and so does the constant background thinking about food that many patients describe. And it improves how your body handles blood sugar, which matters because unstable blood sugar drives cravings.
Patients rarely describe it as willpower arriving. They describe the noise stopping.
What the Trials Actually Showed
The key study for weight is SURMOUNT-1, published in the New England Journal of Medicine in 2022. It followed more than 2,500 adults living with obesity, or with overweight and a related health condition, for 72 weeks. None of them had diabetes.
On the highest dose, average weight loss was around 21 percent of body weight. On the lowest dose, around 15 percent. The placebo group, who received the same lifestyle advice, lost around 3 percent.
Two things matter in those numbers. They are averages, and individual responses vary widely. And the weight loss happened alongside changes to eating and activity, not instead of them.
What the Trials Do Not Tell You
A later study, SURMOUNT-4, looked at what happens when people stop. Those who switched to placebo after nine months regained a substantial part of the weight they had lost over the following year. Those who continued kept losing.
This is the part of the conversation that many providers skip. Obesity is a chronic condition, and for many patients tirzepatide is a long-term medicine. Where the dose is reduced, it needs a plan: protecting muscle, keeping protein high, strength training, and changing the habits that the medicine made easier.
Side Effects
The most common side effects are gastrointestinal: nausea, diarrhoea, vomiting, constipation and a markedly reduced appetite. They are usually worst in the first weeks and after each dose increase, which is why the dose is raised slowly, over months.
Less common but serious risks include inflammation of the pancreas and gallbladder problems. Tirzepatide is not used in anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, and it is not used in pregnancy. It can also make the oral contraceptive pill less reliable, particularly in the first weeks and after each dose increase, so a backup method is advised.
A Word on Where It Comes From
Demand for this class of medicine has outstripped supply in many countries, and regulators have issued warnings about falsified and unregulated versions. In Lagos, the practical rule is simple. Know where your medicine comes from, and never inject something bought through social media or from a friend of a friend.
Who It Is For
Tirzepatide is considered for adults living with obesity, or with overweight and a weight-related condition such as high blood pressure, prediabetes or sleep apnoea, where changes to diet and activity alone have not been enough.
It is not a shortcut to drop a dress size before an event, and it is not appropriate for everyone who asks for it. If you have dieted repeatedly and watched the weight return, Why Diets Do Not Work explains the biology behind that pattern.
What Supervised Use Looks Like at Bluorchid
It begins with a medical weight loss consultation: your history, your current medicines, your goals, and tests where they are needed. If tirzepatide is right for you, you start on the lowest dose and step up gradually, with a doctor reviewing how you are tolerating it at each stage.
Alongside it, we look at the things that decide whether a result lasts: protein, strength, sleep, and what happens when the dose eventually comes down.
Common Questions
How quickly does Mounjaro work?
Appetite often changes within the first few weeks, but weight loss itself is gradual. The dose starts low and is usually increased in steps about four weeks apart, and in the trials most of the loss built up over the first several months.
Is Mounjaro the same as Ozempic?
No. Ozempic is semaglutide, which acts on GLP-1 alone. Mounjaro is tirzepatide, which acts on both GLP-1 and GIP. In head-to-head studies tirzepatide has produced greater average weight loss, although both are effective medicines.
Will I have to take it forever?
Not necessarily, but stopping without a plan often leads to regain. Some patients continue on a maintenance dose, others reduce it gradually with a structured plan for eating, strength and follow-up. It is a decision made with your doctor, not alone.
Can I use it if I am planning a pregnancy?
Tirzepatide is not used in pregnancy or while breastfeeding. If you are planning to conceive, speak to your doctor well in advance so the medicine can be stopped safely beforehand.